FR2310133B2 - - Google Patents

Info

Publication number
FR2310133B2
FR2310133B2 FR7513932A FR7513932A FR2310133B2 FR 2310133 B2 FR2310133 B2 FR 2310133B2 FR 7513932 A FR7513932 A FR 7513932A FR 7513932 A FR7513932 A FR 7513932A FR 2310133 B2 FR2310133 B2 FR 2310133B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7513932A
Other versions
FR2310133A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7513932A priority Critical patent/FR2310133A2/fr
Priority to BE166547A priority patent/BE841251R/fr
Priority to US05/682,283 priority patent/US4083961A/en
Priority to DE2619667A priority patent/DE2619667C2/de
Priority to ES447803A priority patent/ES447803A2/es
Priority to GB18369/76A priority patent/GB1551275A/en
Publication of FR2310133A2 publication Critical patent/FR2310133A2/fr
Application granted granted Critical
Publication of FR2310133B2 publication Critical patent/FR2310133B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7513932A 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne Granted FR2310133A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7513932A FR2310133A2 (fr) 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne
BE166547A BE841251R (fr) 1975-05-05 1976-04-28 Procede d'obtention d'un activateur du plasminogene
US05/682,283 US4083961A (en) 1975-05-05 1976-05-03 Plasminogen activator pharmaceutical compositions
DE2619667A DE2619667C2 (de) 1975-05-05 1976-05-04 Pharmazeutisches Mittel
ES447803A ES447803A2 (es) 1975-05-05 1976-05-05 Procedimiento de obtencion de un activador del plasminogeno.
GB18369/76A GB1551275A (en) 1975-05-05 1976-05-05 Process for the preparation of plasminogen activators and pharmaceutical compositions containing plasminogen activators obtained by the process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7513932A FR2310133A2 (fr) 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne

Publications (2)

Publication Number Publication Date
FR2310133A2 FR2310133A2 (fr) 1976-12-03
FR2310133B2 true FR2310133B2 (fr) 1978-12-01

Family

ID=9154824

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7513932A Granted FR2310133A2 (fr) 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne

Country Status (6)

Country Link
US (1) US4083961A (fr)
BE (1) BE841251R (fr)
DE (1) DE2619667C2 (fr)
ES (1) ES447803A2 (fr)
FR (1) FR2310133A2 (fr)
GB (1) GB1551275A (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462165A2 (fr) * 1973-12-03 1981-02-13 Fabre Sa Pierre Procede perfectionne de preparation d'activateur du plasminogene
GB2121050B (en) * 1979-07-05 1986-03-26 Genentech Inc Preparation of functional human urokinase proteins
ES494343A0 (es) * 1979-07-27 1981-10-01 Procedimiento de obtencion de un activador del plasminogeno
FR2483234A2 (fr) * 1980-05-29 1981-12-04 Fabre Sa Pierre Composition ophtalmique contenant un activateur du plasminogene
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
US5112755A (en) * 1982-04-15 1992-05-12 Genentech, Inc. Preparation of functional human urokinase proteins
US4853330A (en) * 1983-04-07 1989-08-01 Genentech, Inc. Human tissue plasminogen activator
GT198302091A (es) * 1982-05-05 1984-10-25 Activador de plasminogeno de tejido humano a),b),c).
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3512908A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel
US5120715A (en) * 1988-12-12 1992-06-09 Takeda Chemical Industries, Ltd. Method for purifying fibroblast growth factor protein
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
US5288489A (en) * 1991-08-28 1994-02-22 Orion Therapeutic Systems, Inc. Fibrinolysis and fibrinogenolysis treatment
AU2006200638B2 (en) * 1999-10-01 2007-11-01 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6261820B1 (en) * 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
AU2004201694B2 (en) * 1999-10-01 2006-03-02 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6440414B1 (en) * 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US7033776B2 (en) * 1999-12-17 2006-04-25 Amgen Inc. Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2153200A1 (en) * 1971-09-24 1973-05-04 Choay Sa Stable,pyrogen-free urokinase prepns - from human urine

Also Published As

Publication number Publication date
US4083961A (en) 1978-04-11
DE2619667C2 (de) 1984-12-06
ES447803A2 (es) 1977-07-01
GB1551275A (en) 1979-08-30
BE841251R (fr) 1976-10-28
DE2619667A1 (de) 1976-11-18
FR2310133A2 (fr) 1976-12-03

Similar Documents

Publication Publication Date Title
FR2310133B2 (fr)
JPS5515885Y2 (fr)
JPS5195975U (fr)
JPS5348618Y2 (fr)
JPS5635147B2 (fr)
JPS5225761U (fr)
JPS5531429Y2 (fr)
JPS5282892U (fr)
JPS51123871U (fr)
JPS5280092U (fr)
JPS525892U (fr)
JPS5225911U (fr)
IN142699B (fr)
JPS5222443U (fr)
JPS5212728U (fr)
JPS51140582U (fr)
CH610772A5 (fr)
CH607940A5 (fr)
CH598492A5 (fr)
CH599061A5 (fr)
CH598110A5 (fr)
CH597422B5 (fr)
CH597031A5 (fr)
CH596591B5 (fr)
CH598113A5 (fr)